← Leaderboards
Yuying Liang
University Of Minnesota
$5,110,790
Attributed
$8,829,090
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,829,090 · 8
By mechanism
R01$7,219,656 · 4
R21$1,261,196 · 3
U54$348,238 · 1
Top collaborators
- Hinh Ly7 shared
- Slobodan Paessler5 shared
- Mark R. Schleiss2 shared
- Anna Degraff Tischler2 shared
- Craig John Bierle1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Mark R. Schleiss$10,248,102
- Anna Degraff Tischler$4,782,782
- Craig John Bierle$2,400,280
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionArenavirusVaccinesViralAnimal ModelAnimalsVirulentFamilyVirus DiseasesPichinde VirusBaseMediatingPathogenLaboratoriesMolecularLeadVirusViral Hemorrhagic FeversImmune ResponsePathogenesisDisease OutcomeCessation Of LifeAntiviral AgentsContainment
Grant awards (19)
Development of Broadly Protective Vaccines against New World Arenaviruses$720,588
R01 · FY2025 · AI · contact PI
Immune regulation of arenavirus infections in the placenta$645,296
R01 · FY2025 · HD
Novel multivalent viral vectored tuberculosis vaccines targeting lung immunity$227,848
R21 · FY2024 · AI
Viral Vectored COVID-19 Vaccines in a Guinea Pig Perinatal Infection Model$232,500
R21 · FY2023 · AI
Novel multivalent viral vectored tuberculosis vaccines targeting lung immunity$189,098
R21 · FY2023 · AI
Viral Vectored COVID-19 Vaccines in a Guinea Pig Perinatal Infection Model$193,750
R21 · FY2022 · AI
Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence$730,564
R01 · FY2021 · AI · contact PI
Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence$739,394
R01 · FY2020 · AI · contact PI
Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence$749,142
R01 · FY2019 · AI · contact PI
Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence$757,888
R01 · FY2018 · AI · contact PI
Mechanism of Lassa fever virus Z protein in immune suppression and viral virulence$782,328
R01 · FY2017 · AI · contact PI
Molecular determinants of virulent arenavirus infection in hosts$418,634
R01 · FY2014 · AI · contact PI
Molecular determinants of virulent arenavirus infection in hosts$393,516
R01 · FY2013 · AI · contact PI
Receptor tyrosine kinase signaling and influenza viral RNA synthesis$228,000
R21 · FY2013 · AI · contact PI
Molecular determinants of virulent arenavirus infection in hosts$418,634
R01 · FY2012 · AI · contact PI
Receptor tyrosine kinase signaling and influenza viral RNA synthesis$190,000
R21 · FY2012 · AI · contact PI
Molecular determinants of virulent arenavirus infection in hosts$429,672
R01 · FY2011 · AI · contact PI
Molecular determinants of virulent arenavirus infection in hosts$434,000
R01 · FY2010 · AI · contact PI
Pichinde virus-infected guinea pigs as animal model for human hemorrhagic fever$348,238
U54 · FY2008 · AI · contact PI